{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:25:51Z","timestamp":1773116751806,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J01693"],"award-info":[{"award-number":["2021J01693"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011036","name":"Empire State Development's Division of Science, Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108593","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:02:28Z","timestamp":1747306948000},"page":"108593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation"],"prefix":"10.1016","volume":"162","author":[{"given":"Huifang","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenlu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijun","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108593_bb0005","first-page":"S1742","article-title":"CaGA nanozymes inhibit oxidative stress and protect mitochondrial function in ulcerative colitis therapy","volume":"25","author":"Lin","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioorg.2025.108593_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107663","article-title":"Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid","volume":"213","author":"Wang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.108593_bb0015","doi-asserted-by":"crossref","first-page":"0464","DOI":"10.34133\/research.0464","article-title":"Natural flavonoid-derived enzyme mimics DHK Nase balance the two-edged reactive oxygen species function for wound healing and inflammatory bowel disease therapy","volume":"7","author":"Feng","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.bioorg.2025.108593_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bioorg.2025.108593_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121596","article-title":"Imatinib mitigates experimentally-induced ulcerative colitis: possible contribution of NF-\u03baB\/JAK2\/STAT3\/COX2 signaling pathway","volume":"321","author":"Shalaby","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.108593_bb0030","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3390\/jcm11092302","article-title":"An update on current pharmacotherapeutic options for the treatment of ulcerative colitis","volume":"11","author":"Ferretti","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2025.108593_bb0035","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","article-title":"What does disease progression look like in ulcerative colitis, and how might it be prevented?","volume":"162","author":"Cleveland","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioorg.2025.108593_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/cancers15020475","article-title":"Perspectives of the application of non-steroidal anti-inflammatory drugs in cancer therapy: attempts to overcome their unfavourable side effects","volume":"15","author":"Thiruchenthooran","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108593_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116257","article-title":"Structural modification based on the diclofenac scaffold: achieving reduced colitis side effects through COX-2\/NLRP3 selective inhibition","volume":"268","author":"Ju","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131652","article-title":"Design, synthesis and biological evaluation of new imidazo [1, 2-a] pyridine derivatives as selective COX-2 inhibitors","volume":"1250","author":"Ismael","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108593_bb0055","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","article-title":"Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years","volume":"12","author":"Ju","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108593_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107209","article-title":"Structural modification of natural axinelline a: achieving reduced colitis side effects through balanced COX inhibition","volume":"145","author":"Ju","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/ph15070827","article-title":"Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing","volume":"15","author":"El-Malah","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108593_bb0070","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/eurheartj\/ehae128","article-title":"Aspirin hypersensitivity: a practical guide for cardiologists","volume":"45","author":"Grimaldi","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2025.108593_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110522","article-title":"Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors","volume":"380","author":"Xin","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108593_bb0080","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1248\/bpb.29.1659","article-title":"Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs","volume":"29","author":"Costa","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2025.108593_bb0085","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jcsm.12558","article-title":"Indoprofen prevents muscle wasting in aged mice through activation of PDK1\/AKT pathway","volume":"11","author":"Kim","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bioorg.2025.108593_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.29296\/25419218-2022-04-06","article-title":"Evaluation of analgesic and anti-inflammatory activities of a new isoindoline-1, 3-dione derivative","volume":"71","author":"Trukhanova","year":"2022","journal-title":"Farmaciya (Pharmacy)"},{"key":"10.1016\/j.bioorg.2025.108593_bb0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3998\/ark.5550190.0014.225","article-title":"Design and synthesis of some isoindoline derivatives as analogues of the active anti-inflammatory Indoprofen","volume":"2013","author":"Csende","year":"2013","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2025.108593_bb0100","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bmcl.2008.01.066","article-title":"Isoindol-1, 3-dione and isoindol-1-one derivatives with high binding affinity to \u03b2-amyloid fibrils","volume":"18","author":"Lee","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108593_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2024.134022","article-title":"A dual strategy of direct C (sp3)-H sulfonamidation by cross-dehydrogenative coupling and oxidative hydroxylation-condensation","volume":"160","author":"Lai","year":"2024","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108593_bb0110","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1039\/D1OB01054A","article-title":"Copper-promoted direct amidation of isoindolinone scaffolds by sodium persulfate","volume":"19","author":"Lai","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0115","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/jm301905a","article-title":"Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors","volume":"56","author":"Vitale","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105663","article-title":"Inflammation: biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2","volume":"121","author":"Kaur","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0125","article-title":"Quinic acid ameliorates ulcerative colitis in rats, through the inhibition of two TLR4-NF-\u03baB and NF-\u03baB-INOS-NO signaling pathways","volume":"11","author":"Ghasemi-Dehnoo","year":"2023","journal-title":"Immun. Inflamm."},{"key":"10.1016\/j.bioorg.2025.108593_bb0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/D1MD00280E","article-title":"Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors","volume":"13","author":"Ahmadi","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2025.108593_bb0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.drudis.2020.01.012","article-title":"Flexibility in early drug discovery: focus on the beyond-rule-of-5 chemical space","volume":"25","author":"Caron","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108593_bb0145","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1039\/D1NJ05621B","article-title":"Design, synthesis, characterization, in vitro screening, molecular docking, 3D-QSAR, and ADME-Tox investigations of novel pyrazole derivatives as antimicrobial agents","volume":"46","author":"Chalkha","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2025.108593_bb0150","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1039\/D4FO00952E","article-title":"6-Gingerol ameliorates ulcerative colitis by inhibiting ferroptosis based on the integrative analysis of plasma metabolomics and network pharmacology","volume":"15","author":"Li","year":"2024","journal-title":"Food & Funct."},{"key":"10.1016\/j.bioorg.2025.108593_bb0155","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/nu16142343","article-title":"Hesperetin alleviated experimental colitis via regulating ferroptosis and gut microbiota","volume":"16","author":"Wang","year":"2024","journal-title":"Nutrients"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:25:09Z","timestamp":1762223109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"alternative-id":["S0045206825004730"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108593","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108593"}}